by Scott Miller | Jul 2, 2026
CHAI is pleased to release the 2026 Hepatitis C Treatment Market Memo, the latest in our series of hepatitis C market intelligence publications. A decade ago, curing hepatitis C cost more than US$84,000 per patient. Today, the same cure can be procured at around US$60...
by Scott Miller | Jun 22, 2026
Updated analysis from CHAI tracks the state of African vaccine manufacturing ambitions in 2026 Africa has long relied on other parts of the world for its vaccines, a vulnerability COVID-19 made impossible to ignore. That crisis galvanized African leaders and...
by Scott Miller | Jun 8, 2026
A year after global HIV funding was upended, the damage is still mounting. New nationwide data collected by CHAI across countries in sub-Saharan Africa and Asia tracks what happened to HIV services in 2025 and into early 2026 against the year before — and shows that...
by Scott Miller | May 18, 2026
An assessment of the regional vaccine manufacturing ecosystem across the region, the structural risks to its long-term viability, and targeted recommendations to strengthen it Across Southeast Asia, there is genuine will to build a regional vaccine manufacturing base...
by Scott Miller | May 18, 2026
An assessment of the regional vaccine manufacturing ecosystem the structural risks that threaten its sustainability, and targeted recommendations to address them Latin America and the Caribbean has made real progress in building its own vaccine supply. The share of...
